Herceptin could drastically improve survival rates - The Independent 27th September 2007

The breast cancer drug Herceptin could cut the number of mastectomies and extend lives among the 44,000 breast cancer patients diagnosed in Britain each year. Researchers told the European Cancer Conference in Barcelona yesterday that use of the drug in women with inflammatory breast cancer, a rare and aggressive form of the disease, led to the disappearance of the tumour in more than half of patients when combined with chemotherapy.

Link to Article

Additional Story

New therapy hope for breast cancer - The Telegraph 27th September 2007